pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Federal judge overturns key disability protection law

Sep 25, 2026·read at STAT ↗RegulatoryNegative

A federal judge has reversed a longstanding disability protection ruling, reducing the legal safeguards that favored community-based living over institutional care.

The Justice Department had announced in June that it would stop enforcing statutes that required services to be provided in community settings rather than nursing homes.

Advocates warn the decision could undermine progress on disability rights and may have ripple effects on health policy and service delivery.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Federal judge rolls back landmark disability protections”

read at STAT ↗
1,490 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2National Institutes of HealthUltragenyx Pharmaceutical Inc.
drugs
MIFEPRISTONERare Disease
topics
Cardiology3Endocrinology & Metabolism2Psychiatry & CNS2Vaccine2Rare DiseaseVaccines

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 2d agoNovo workforce down 13,000BioSpace
  • May 12Supreme Court extends mifepristone deadlineSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MFierce Biotech
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT